Pharmaceutical Product Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pharmaceutical Product Manufacturing Market Research Report | ANZSIC C1841 | Jul 2015

Price pressures: Patent expiries and PBS reforms have contributed to falling revenue

IBISWorld’s Pharmaceutical Product Manufacturing market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Industry Statistics & Market Size
Annual Growth 11-16
Annual Growth 16-21
Add to Cart
Add to Cart
Industry Analysis & Industry Trends

The Pharmaceutical Product Manufacturing industry is dominated by major global pharmaceutical groups, although only a small number are engaged in local manufacture of active pharmaceutical ingredients. An increasing number of firms are limiting their Australian activity to the later stages of the manufacturing process, including dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their Australian activities to purely distribution.

As with those in the global pharmaceutical industry, domestic players are currently contending with the fallout of the patent cliff. Since 2011, some of the world’s highest selling drugs have lost patent protection... purchase to read more

Industry Report - Industry Investment Chapter

The Pharmaceutical Product Manufacturing industry has a medium level of capital intensity, reflecting the level of capital tied up in manufacturing facilities capable of producing, high-cost, high-technology drugs. In 2015-16, for every dollar that the overall industry spends on capital, $7.80 is spent on wages. Capital labour intensity ratios vary between product segments, with the patented prescription product segment having a considerably higher ratio than the generic and OTC product segments.

Falling levels of capital investment growth have recently characterised the industry, with fewer players investing in updating manufacturing capacity or equipment... purchase to read more


Industry ProductsRelated ReportsTable of Contents

What is the Pharmaceutical Product Manufacturing Industry?

The industry comprises companies that manufacture various medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Manufacturing activities include the manufacture of active pharmaceutical ingredients and synthesis of chemical ingredients, through to late-stage packaging and fill-finish activities.

Industry Products
Patented prescription pharmaceuticalsOTC and complementary medicinesGeneric prescription pharmaceuticals
Industry Activities
Antibacterial, antibiotic and antitoxinVaccineVitamin productHerbal drugAmpoule, medicinal capsule, medicinal ointment and vialBiotechnological pharmaceutical and medicinal productsSerum and blood serumDiagnostic substance

View Sample
Select Clients